HIGH-DOSE METHOTREXATE THERAPY

被引：11

作者：

BELL, R

SULLIVAN, JR

MOON, WJ

HURLEY, TH

机构：

[1] ROYAL MELBOURNE HOSP,PARKVILLE 3050,VICTORIA,AUSTRALIA

[2] ROYAL MELBOURNE HOSP,DIV MED,PARKVILLE 3050,VICTORIA,AUSTRALIA

[3] ROYAL MELBOURNE HOSP,SPECIAL ONCOL CLIN,PARKVILLE 3050,VICTORIA,AUSTRALIA

来源：

MEDICAL JOURNAL OF AUSTRALIA | 1977年 / 1卷 / 08期

关键词：

D O I：

10.5694/j.1326-5377.1977.tb130665.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：247 / 249

页数：3

共 14 条

[1]

CAPIZZI R, 1974, ASCO ABSTR, P182

[2]

DJERASSI I, 1968, P AM ASSOC CANC RES, V9, P18

[3]

DJERASSI I, 1972, CANCER, V30, P22, DOI 10.1002/1097-0142(197207)30:1<22::AID-CNCR2820300105>3.0.CO

[4]

2-B

[5]

FREI E, 1975, NEW ENGL J MED, V292, P846

[6]

FREI E, 1975, NEW ENGL J MED, V292, P107

[7] METHOTREXATE TOXICITY - CORRELATION WITH DURATION OF ADMINISTRATION, PLASMA LEVELS, DOSE AND EXCRETION PATTERN [J].

GOLDIE, JH ;

HARRAP, KR ;

PRICE, LA .

EUROPEAN JOURNAL OF CANCER, 1972, 8 (04) :409-&

[8] ADJUVANT METHOTREXATE AND CITROVORUM-FACTOR TREATMENT OF OSTEOGENIC SARCOMA [J].

JAFFE, N ;

FREI, E ;

TRAGGIS, D ;

BISHOP, Y .

NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (19) :994-997

[9]

LEVITT M, 1973, CANCER RES, V33, P1729

[10] MULTIPLE DRUG THERAPY FOR DISSEMINATED MALIGNANT TUMOURS [J].

PRICE, LA ;

GOLDIE, JH .

BRITISH MEDICAL JOURNAL, 1971, 4 (5783) :336-&

← 1 2 →